Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (325)

clinicaltrialsPublishedShowing 251–256 of 256 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01017250	Radiosurgery and Avastin for Recurrent Malignant Gliomas	completed	N/A	15	Duke UniversityOTHER	1	Feb 28, 2014	clinicaltrials
NCT00780819	Borderzone Sampling(BZS)	completed	N/A	10	Maastricht University Medical CenterOTHER	1	May 14, 2013	clinicaltrials
NCT01798771